Illustrative image – not actual.The proposed investment will be uitilsed to increase production capacities with creation of new manufacturing blocks, warehouse expansion and utility augmentation. Piramal Pharma currently has a manufacturing facility comprising three units multiple production blocks with a total reactor volume exceeding 1,000 kilo ltr.
Piramal Group is also keen on adding capacities through acquisitions in and around Hyderabad with an aim to increase active pharmaceutical ingredient (API) manufacturing. In addition, the company also plans to shift their pharmaceutical manufacturing operations from other states to a new location in Hyderabad, Telangana.
